|1.||Nordström, Peter: 5 articles (04/2011 - 01/2006)|
|2.||Jokinen, Jussi: 5 articles (04/2011 - 01/2006)|
|3.||Nordström, Anna-Lena: 5 articles (04/2011 - 01/2006)|
|4.||Taal, Babs G: 3 articles (01/2009 - 09/2004)|
|5.||Vinik, Aaron I: 2 articles (05/2015 - 04/2013)|
|6.||Mann, J John: 2 articles (03/2014 - 10/2006)|
|7.||Engelborghs, Sebastiaan: 2 articles (01/2014 - 09/2013)|
|8.||Vermeiren, Yannick: 2 articles (01/2014 - 09/2013)|
|9.||De Deyn, Peter P: 2 articles (01/2014 - 09/2013)|
|10.||Nakamura, Naoto: 2 articles (01/2012 - 08/2009)|
|1.||Carcinoid Tumor (Carcinoid)
05/01/2007 - "This study shows promise for plasma 5-HIAA as a useful marker for monitoring carcinoid disease. "
10/01/1999 - "66-100% positive results of this treatment have been reported in the carcinoid syndrome with a 50-91% decrease in 5-HIAA secretion. "
05/01/2013 - "The indications for dose increase were worsening carcinoid syndrome (n = 60), radiographic progression (n = 33), and rising urine 5-HIAA (n = 6). "
01/01/2013 - "It is important to recognize that OTC medication may cause increased 'false-positive' 5-HIAA excretion to prevent undue patient anxiety and unnecessary further investigation for carcinoid disease. "
06/01/2012 - "5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients."
05/01/1996 - "There was no significant correlation between 5-HIAA levels and gender, or age of the patients, or seizure duration. "
05/01/1996 - "After the seizure, a statistically significant decrease of 5-HIAA serum levels was observed over both ECTs. "
03/01/1990 - "No differences were found in CSF, L-TRP, 5-HIAA, or HVA concentrations between 11 neurologically normal controls and 15 interictal (no seizures for greater than 24 h) and 20 postictal (within 50 min of seizure) samples from epileptic patients. "
10/01/1980 - "However, a dose of 20 mg/kg did significantly reduce 5-HIAA content although it did not alter seizure activity. "
09/01/2002 - "During a Delirium Tremens with seizure at onset, there are no statistically significant changes in 5-HIAA and HVA levels in the cerebrospinal fluid. "
|3.||Mood Disorders (Mood Disorder)
03/01/1993 - "5. The augmentation of 5-HIAA level after VPA administration and after stress, in correlation with the decrease of 5-HIAA that is observed in depression, support the hypothesis that VPA may be effective in affective disorders by influencing the serotoninergic system."
01/01/2008 - "To study the interrelationship of suicide risk factors: low CSF 5-HIAA and the DST non-suppression in mood disorder patients with and without an index suicide attempt. "
12/01/2002 - "Furthermore, considering the relationship among diurnal rhythm, emotional disturbance and the mPFC, the site-specific diurnal rhythmicity of 5-HIAA in the mPFC may be a useful index in neurochemical studies on emotional states, such as seen in affective disorders and psychiatric diseases."
06/01/1992 - "Early CSF studies have indicated decreased CSF 5-HIAA in patients recently attempting suicide and follow-up studies of large samples of mood-disorder patients confirm the original hypothesis that low CSF 5-HIAA predicts suicide risk after attempted suicide. "
01/30/2009 - "Low CSF 5-HIAA and DST non-suppression are orthogonal biologic risk factors for suicide in male mood disorder inpatients. "
07/01/2004 - "Measurement of 5-HIAA levels in spot urine is not helpful in the diagnosis of acute appendicitis."
05/01/2012 - "In this study, we investigated the value of 5-HIAA levels in spot urine in the diagnosis of acute appendicitis. "
03/01/2008 - "The aim of this study was to measure the urinary 5-HIAA concentrations of patients presenting with symptoms of acute appendicitis to determine the sensitivity and specificity of urinary 5-HIAA levels for diagnosing acute appendicitis. "
05/01/2012 - "The measurement of urinary 5-HIAA levels is not an ideal diagnostic tool for ruling out or determination of acute appendicitis."
05/01/2012 - "The urinary 5-HIAA was measured by an enzyme-linked immunosorbent assay in the spot urine of 70 patients who presented to the emergency department with a clinical picture of acute appendicitis. "
01/01/2006 - "The results indicate that suicide attempters with low CSF 5-HIAA in this sample tended to experience more discomfort and pain during self-inspection. "
04/01/2005 - "The pathological decrease of NE and 5-HIAA in the CSF points to the crucial role of noradrenergic and serotonergic transmitter systems in the generation, modulation, and perpetuation of chronic and episodic pain syndromes. "
04/01/2005 - "In patients with chronic and episodic pain, NE and 5-HIAA were positively correlated to the duration of disease and were significantly lower than in the control group. "
01/15/1999 - "High serum concentrations of 5-HIAA and TRP showed a significant relation to low pain scores (5-HIAA: P = .030; TRP: P = .014). "
10/01/1989 - "The level of 5-HIAA in patients with pain was 66.48 +/- 13.67 ng/ml, while in those without pain was 25.05 +/- 13.25 ng/ml; the difference was statistically significant, p = 0.001. "
|1.||Serotonin (5 Hydroxytryptamine)
|3.||Adrenocorticotropic Hormone (ACTH)
|9.||Pargyline (Pargyline Hydrochloride)
|10.||Ethanol (Ethyl Alcohol)
|5.||Transplantation (Transplant Recipients)